MaaT Pharma SA (EPA: MAAT)
France
· Delayed Price · Currency is EUR 7.88
-0.12 (-1.50%)
Dec 20, 2024, 5:27 PM CET
MaaT Pharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -24.14 | -19.72 | -13.71 | -9.02 | -5.3 | - | Upgrade
|
| Depreciation & Amortization | 1.39 | 0.79 | 0.37 | 0.29 | 0.13 | - | Upgrade
|
| Other Amortization | 0.11 | 0.08 | 0.06 | 0.04 | 0.04 | - | Upgrade
|
| Stock-Based Compensation | 1.29 | 0.87 | 0.65 | 0.79 | 0.02 | - | Upgrade
|
| Other Operating Activities | -0.14 | -0.31 | 0.08 | 0.19 | 0.04 | - | Upgrade
|
| Change in Accounts Receivable | 0.02 | 0.35 | -0.32 | -0.39 | - | - | Upgrade
|
| Change in Inventory | -0.1 | -0.14 | -0.01 | -0.03 | - | - | Upgrade
|
| Change in Accounts Payable | 2.14 | 1.84 | 2.04 | 1.07 | -0.28 | - | Upgrade
|
| Change in Other Net Operating Assets | 1.23 | -2.43 | -1.75 | -0.86 | -0.48 | - | Upgrade
|
| Operating Cash Flow | -18.2 | -18.67 | -12.61 | -7.93 | -5.84 | - | Upgrade
|
| Capital Expenditures | -0.74 | -1.09 | -0.66 | -0.24 | -0.32 | - | Upgrade
|
| Investment in Securities | -0.06 | 0.01 | -0.2 | - | -0.18 | - | Upgrade
|
| Other Investing Activities | 0.54 | 0.64 | 0.05 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.2 | -0.44 | -0.82 | -0.24 | -0.49 | - | Upgrade
|
| Long-Term Debt Issued | - | - | 7.48 | 0.46 | 3.52 | - | Upgrade
|
| Long-Term Debt Repaid | - | -4.19 | -1.93 | -0.95 | -0.58 | - | Upgrade
|
| Net Debt Issued (Repaid) | -2.33 | -4.19 | 5.55 | -0.49 | 2.94 | - | Upgrade
|
| Issuance of Common Stock | 17.25 | 12.59 | 0.1 | 32.44 | 17.95 | - | Upgrade
|
| Repurchase of Common Stock | -0.07 | -0.08 | -0.14 | - | - | - | Upgrade
|
| Other Financing Activities | -0.38 | -0.18 | -0.15 | -0.1 | -0.05 | - | Upgrade
|
| Financing Cash Flow | 14.47 | 8.14 | 5.36 | 31.56 | 20.84 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | -0 | - | - | - | Upgrade
|
| Net Cash Flow | -3.94 | -10.97 | -8.06 | 23.39 | 14.5 | - | Upgrade
|
| Free Cash Flow | -18.94 | -19.76 | -13.27 | -8.17 | -6.16 | - | Upgrade
|
| Free Cash Flow Margin | -736.76% | -887.03% | -927.76% | -840.23% | - | - | Upgrade
|
| Free Cash Flow Per Share | -1.59 | -1.74 | -1.34 | -3.37 | -5.97 | - | Upgrade
|
| Cash Interest Paid | 0.27 | 0.18 | 0.15 | 0.1 | 0.05 | - | Upgrade
|
| Levered Free Cash Flow | -8.77 | -11.1 | -8.04 | -4.99 | -4.57 | - | Upgrade
|
| Unlevered Free Cash Flow | -8.45 | -10.85 | -7.92 | -4.92 | -4.55 | - | Upgrade
|
| Change in Net Working Capital | -4.55 | -0.97 | 0.07 | 0.23 | 1.13 | -0.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.